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Creatinine correctionWe have analyzed the trends in the body-weight-adjusted urinary monoethyl phthalate (MEP) concentrations
and the diethyl ethyl phthalate (DEP) daily intake estimates in the general Canadian population (aged 6-49
years) using the Canadian Health Measures Survey 2007–2009 dataset. The creatinine correction approach, as
well as the urine volume approach in a simple one compartment model were used to calculate the daily urinary
MEP excretion rates and DEP intake rates in individual survey participants. Using multiple regression models,
we have estimated least square geometric means (LSGMs) of body-weight-adjusted MEP concentration, daily
excretion and intake rates among different age groups and sex. We observed that body weight affects the trends
in the MEP concentrations signiﬁcantly among children (aged 6–11 years), adolescents (aged 12–19 years) and
adults (aged 20–49 years). The body-weight-adjusted MEP concentrations in children were signiﬁcantly higher
than those in adults. On the other hand the DEP daily intakes in children were signiﬁcantly lower than those in
adults. We did not observe any differences in the DEP daily intake rates between males and females. Although
the urinary MEP concentrations are correlated well with DEP daily intake estimates in the overall population,
one should be cautious when directly using the urinary concentrations to compare the intake trends in the
sub-populations (e.g. children vs. adults) as these trends are governed by additional physiological factors. The
DEP daily intake calculated using the creatinine approach and that using the urine volume approachwere similar
to each other. The estimated geometric mean and 95th percentile of DEP daily intake in the general Canadian
population are 2 and 20 μg/kg-bw/day, respectively. These daily intake estimates are signiﬁcantly lower than
the US Environmental Protection Agency's oral reference dose of 800 μg/kg-bw/day.
Crown Copyright © 2014 Published by Elsevier B.V. All rights reserved.1. Introduction
Diethyl phthalate (DEP) belongs to the class of synthetic chemicals
called “phthalates”. DEP has been widely used as a solvent and ﬁxative
in a variety of consumer products such as fragrances, cosmetics, and
personal care products (PCPs) such as deodorants, lotions, creams,
soaps, and hair care preparations (Houlihan et al., 2000; Hubinger andttawa, Ontario, K2W 0A8.
.ca (G. Saravanabhavan).
r B.V. All rights reserved.Havery, 2006; Koniecki et al., 2011; Romero-Franco et al., 2011). For
example, Koniecki et al. analyzed 252 cosmetics and PCPs for phthalate
diesters and found that DEP is not only present in 103 out of 252
products analyzed, but also at concentrations much higher than other
phthalate esters such as dibutyl-, di(2-ethylhexyl)- and dimethyl
phthalates (DBP, DEHP and DMP) (Koniecki et al., 2011). In addition
to cosmetics, DEP is also used as a plasticizer in cellulose-based plastic
ﬁlms and sheets, consumer articles such as toothbrushes, and automo-
tive parts (WHO, 2003). Moreover, DEP and other phthalate diesters
have been identiﬁed and quantiﬁed in indoor air, and dust samples
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could occur frommultiple sources and pathways (Fromme et al., 2004).
Like other phthalates, DEP undergoes rapid metabolism in humans.
DEP is hydrolyzed to form the major metabolite monoethyl phthalate
(MEP) which further hydrolyzes to phthalic acid or is conjugated to
glucoronic acid and excreted (Silva et al., 2004). Pharmacokinetic stud-
ies in animals indicate that urinaryMEPhas been identiﬁed as themajor
metabolite after oral or intravenous administration of DEP (Albro and
Moore, 1974; Kao et al., 2012). TheMEP could undergo further transfor-
mations to formmetabolites with aldehyde-, keto-, and carboxylic acid-
functional groups (ATSDR, 1995). These oxidative metabolites consti-
tute minor metabolites of DEP which have not been identiﬁed/detected
in human biomonitoring studies regularly. Consistent with animal
studies, MEP has been detected widely in human urine samples in
several general population surveys (Becker et al., 2009; Blount et al.,
2000; CDC, 2012; Saravanabhavan et al., 2013; Silva et al., 2004). Such
biomonitoring data can be used to characterize the body burden (i.e. in-
ternal exposure) of synthetic chemicals in the general population (Koch
and Calafat, 2009; Thornton et al., 2002). Results from the Canadian
Health Measures Survey (CHMS) show that urinary MEP concentration
is the highest among the phthalate metabolites measured (Health
Canada, 2010) suggesting DEP body burden would be higher compared
to that of other phthalates in the general population. Moreover, the
urinary MEP concentration in the general population is observed to
increase with age (Saravanabhavan et al., 2013). However, as children
have relatively lower body weights than adolescents and adults, the
urinary excretion expressed per kg body weight basis in children may
be higher despite lower urinary MEP concentration. On the other hand,
children have lower total daily urine output compared to adults. This
fact suggests that for a given exposure dose of DEP, the urinary concen-
tration of MEP in children would be relatively higher than that of adults.
Thus, the body weight and the total urine output exert opposing effects
in determining the daily intake (μg/kg-bw/day) of DEP using urinary
MEP concentrations.
In this paper, we ﬁrst illustrate the effect of body weight on the
urinary MEP concentration by analyzing the MEP data from the CHMS
2007–2009. We have used the creatinine correction approach as well as
urine volume approach in a simple one compartment model to calculate
the daily urinary MEP excretion rates and DEP intake rates in individual
survey participants. Using multiple regression models, we have estimat-
ed least square geometric means (LSGMs) of body-weight-adjusted
MEP concentration, daily excretion and intake rates among different
age groups and sex.
2. Materials and methods
2.1. Data source
The CHMS 2007–2009 collected biological specimens from 5604
Canadians representing 96.1% of overall Canadian population aged 6
to 79 years. MEP and other urinary phthalate metabolites were mea-
sured in a subsample of 3237 participants between 6 and 49 years of
age. All children and youths aged 6 to 19 years at the time of the house-
hold interview were selected for this measure. Adults aged 20 to
49 years old were selected if there were no youths 6 to 11 years old in
their household.
MEP and other phthalatemetabolitesweremeasured in urine using a
previously published analytical method (Langlois et al., 2012) at Centre
de Toxicologie du Québec (CTQ).
2.2. Statistical analysis
The data were analyzed with SAS 9.2 (SAS Institute Inc., USA),
SUDAAN 10.0.1 software (RTI International, USA) and R (R Core Team,
2013). Variance estimates were produced using bootstrap weights,
taking into account the 11 degrees of freedom as suggested in CHMSdata user guide (Health Canada, 2010). All analyses were weighted
using the CHMS cycle 1 survey weights (phthalates subsample) in
order to be representative of the Canadian population. MEP concentra-
tions that were below the limit of detection (LOD) were assigned a
value of LOD/2.
2.3. Regression models
Urinary MEP excretion rate and DEP daily intake rate were calculat-
ed as described below for each CHMS study participant. Least squares
geometric means (LSGMs) and associated 95% conﬁdence intervals
were computed using multiple regression models via SUDAAN's proc
REGRESS. Since the MEP excretion rate and DEP daily intakes distribu-
tions were skewed, their log transformations were used in the regres-
sion models. Geometric means and 95% conﬁdence intervals were
back transformed to the original scale by exponentiation. The models
included age group (children 6–11 years, adolescents 12–19 years and
adults 20–49 years), and sex, as well as the interaction term age × sex
in order to obtain LSGM estimates for each age group by sex. This
model provided comparisons of LSGM for selected groups (e.g. males
vs. females) that were adjusted statistically so that participants had
comparable levels of all other covariates. Satterthwaite-adjusted statis-
tics were used to test the signiﬁcance of the regression coefﬁcients.
T-tests were used to compare LSGMs between categories. Statistical
signiﬁcance was evaluated at p b 0.05, but was Bonferroni-adjusted
depending on the number of comparisons. The model assumptions of
normality and homoscedasticity were tested by visual examination of
the residuals from the regression equations and satisﬁed for all the
models considered.
2.4. Estimation of creatinine excretion rate (CER)
Urinary creatinine concentration wasmeasured in all participants in
CHMS 2007–2009. As CHMS did not measure urine ﬂow rate, we have
estimated daily creatinine excretion rate in all participants using the
Mage equations (from Huber et al., 2010). The Mage equations use
age, height, and weight of individual participants to estimate their
daily creatinine excretion rate. The adiposity adjustment (discussed
in the supplemental information (Huber et al., 2010)) was applied to
all participants and the body surface area adjustment was applied
to children under the age of 18 years. Median body mass index (BMI)
by age for the adiposity adjustment was computed using the entire
CHMS sample (n = 3224). The CHMS phthalates subsample dataset
had 174 childrenwho exceeded the height limits in theMage equations
(186 cm for males and 172 cm for females). The Mage equations were
applied directly to the observed heights in order to extrapolate creati-
nine excretion rates for these participants. The predicted excretion
rates for these individuals appeared to be reasonable despite the
extrapolation.
2.5. Estimation of urinary ﬂow rate
Since participant's urinary ﬂow rate (mL/min) was not measured
in CHMS, values fromNHANES (available online at http://wwwn.cdc.
gov/nchs/nhanes/search/datapage.aspx?Component=Laboratory
&CycleBeginYear=2009) were randomly assigned to the CHMSpartic-
ipants. Three urinary ﬂow variables were available on the NHANES data
ﬁle, and the ﬁrst non-missing value was chosen in order to represent a
single spot sample protocol. The imputation was carried out in two
ways — one matching CHMS and NHANES participants by age and sex,
and another matching age, sex and BMI. To match BMI, both NHANES
and CHMS participants were separated into BMI quartiles within each
age and sex group. For example, CHMS participants falling into the
ﬁrst CHMS BMI quartile for a given age and sex were matched to
NHANES participants in the ﬁrst NHANES BMI quartile for the same
age and sex. The urinary ﬂow rate data was used to calculate the total
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nine approach included the BMI adjustment, we preferred to use the
latter method (matching age, sex and BMI) to compute the urinary
ﬂow rate and used them to estimate excretion rates and daily intakes.
2.6. Estimation of urinary MEP excretion rate
The urinary MEP excretion rate was calculated using CER as follows
UER μg=kg BW=dayð Þ ¼
UCCr
μg
g Cr
 
 CER g
day
 
BW kgð Þ ð1aÞ
The UER is the body-weight-adjusted urinary excretion rate. The
UCCr is the creatinine adjusted urinary MEP concentration. In CHMS,
urinary creatinine concentration was measured in all participants.
Therefore, UCCr is calculated for each participants by dividing his or
her urinary MEP concentration in (μg/L) by his or her respective creati-
nine concentration (μg/L)] and the BW refers to the body weight. The
CER is calculated using the Mage equations (see previous section).
The urinary MEP excretion rate for individuals was also calculated
using total estimated daily urine output as follows:
UER μg=kg BW=dayð Þ ¼
UC
μg
L
 
 V24h
L
day
 
BW kgð Þ ð1bÞ
The V24h is the total urine output per day and is calculated for each
participant based on the imputation of urinary ﬂow rate from the
NHANES 2009–2010 dataset (see previous section). Since this imputa-
tion process introduced additional uncertainty, the imputation was
repeated 500 times. Random sampling from existing data is known as
bootstrapping (Efron and Tibshirani, 1986). For each bootstrap sample
of urinary ﬂow rates drawn from NHANES, the UER was estimated
using Eq. (1b) and the data were ﬁt using the samemultiple regression
model to produce the LSGM and 95% conﬁdence limit for each age and
sex groups. Since this process was repeated 500 times, the results of
the bootstrap procedure produced 500 LSGMs, 500 conﬁdence intervals
and 500 sets of between group p-values. A bootstrap sample size of 500
was chosen as a balance between processing time and stability of the
ﬁnal estimates. With a bootstrap sample size of 500, repeated applica-
tions of the bootstrap procedure yielded median LSGMs and associated
conﬁdence intervals that were stable to two signiﬁcant ﬁgures. Varia-
tion of the 500 LSGM estimates represents uncertainty due to the
bootstrappingprocess. Theuncertainty introduced by thebootstrapping
process was compared to the sampling variability in the LSGM estima-
tors by computing the width of the 95% conﬁdence interval of LSGMs
among the 500 bootstrap runs and comparing it to the average conﬁ-
dence interval width within each bootstrap run (i.e. the usual 95%
conﬁdence interval for the LSGM). For this analysis, the bootstrapuncer-
tainty ranged between 31% and 62% of the sampling variability, depend-
ing on age group, endpoint and method of bootstrap sample matching.
The results were summarized using the median LSGM and conﬁdence
interval and the proportion of tests that were rejected out of the 500
bootstrap samples.
2.7. Daily intake estimation of DEP
The daily intake of DEP was estimated for each participant using the
following equations (David, 2000; Koch et al., 2003):
Daily intake μg=kg BW=dayð Þ ¼
UER
μg
day  kg BW
 
FUE
 MWD
MWM
ð2ÞThe fractional urinary excretion (FUE) is deﬁned as the fraction of
the DEP exposure dose that is excreted as MEP in urine and calculated
on a per-mole-basis. To the best of our knowledge the FUE value for
MEP is currently not available. Previous works used MnBP FUE value
of 0.69 as a surrogate for MEP in the daily intake estimations (Koch
et al., 2003), probably due to the fact that both MEP and MnBP have
similarmolecular structurewith linear alkyl side chain. This information
is corroborated by the results from a pharmacokinetic study in dogs in
which70–77%of the administeredDEP dose (oral aswell as intravenous
routes)was excreted asMEP in urine (Kao et al., 2012).MWD andMWM
are the molecular weights of the diester (DEP; 222.24 g/mole) and the
monoester (MEP; 194.18 g/mole) respectively.
The daily intake of DEP for each study participants was computed
using Eq. (2) and ﬁtted into multiple regression models to derive re-
spective LSGM estimates for the Canadian population.
3. Results
3.1. Effect of body weight on urinary MEP concentration
The effect of body weight on the urinary metabolite concentrations
among different age groups is presented in Fig. 1a and b. The body-
weight-adjusted model (Fig. 1a) included the volumetric concentration
of MEP adjusted body weight (μg/L/kg-bw), age, sex, creatinine, age ×
creatinine and age × sex interactions. In the unadjusted model (Fig. 1b)
volumetric MEP concentration (μg/L) was used and included all the
above variables.
In the unadjusted model, the LSGM concentration (μg/L) of MEP
in male children (38.6 μg/L) was signiﬁcantly lower than those in
the adult age groups (54.9 μg/L). In addition, in the adolescent age
group, females (62.1 μg/L) had signiﬁcantly higher MEP concentra-
tions compared to males (47.3 μg/L). Overall, females had higher
concentration of MEP than males; however, the differences were
not signiﬁcant. On the other hand, in the body-weight-adjusted
model, the LSGM estimate of urinary MEP was signiﬁcantly higher
in male children (1.16 μg/L/kg-bw) compared to male adolescents
(1.08 μg/L/kg-bw) and adults (0.67 μg/L/kg-bw). Moreover, overall
females have signiﬁcantly higher MEP concentrations compared to
males for all ages (i.e., 6 to 49 years).
3.2. Estimation of urinary MEP excretion rate and DEP daily intakes using
creatinine correction approach
Fig. 2a and b shows the LSGM estimates of urinary MEP excretion
rates in Canadians based on their creatinine excretion rate. The effect
of body weight on the trends in MEP excretion rate was evaluated by
comparing the body-weight-adjusted LSGM estimates of MEP (Fig. 2a)
with that of unadjusted LSGM estimates (Fig. 2b). The regression
models were adjusted for age, sex and age × sex interactions. Similar
trends in MEP excretion rates were observed in both cases: female
and male children had signiﬁcantly lower MEP excretion rates com-
pared to their counterparts in adolescents and adults; however, signiﬁ-
cant difference in the excretion rates exists only in males between
adolescents and adult categories. Moreover, the LSGM MEP estimates
ofmales and femaleswithin individual age groups aswell as in the over-
all population were insigniﬁcant. As daily intake estimates are propor-
tional to the daily excretion rates (ref. Eq. (2)), they show a similar
trend with respect to age and sex.
3.3. Estimation of urinary MEP excretion rate and DEP daily intakes using
urine ﬂow rate approach
As mentioned above, the urine ﬂow rate information from NHANES
was randomly assigned to the CHMS participants based on age, sex and
BMI. This imputation processwas repeated 500 times and after each im-
putation, the LSGM estimates (and the corresponding 95% CIs) for MEP
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Fig. 1. Trends in the least square geometric mean (LSGM) estimates of urinary monoethyl phthalate (MEP) concentration among different age groups in the general Canadian population.
Whiskers represent the upper 95% conﬁdence intervals on the LSGM. Statistically signiﬁcant (p b 0.05) differences are noted with an asterisk (*). a: The body-weight-adjustedMEP concen-
tration was signiﬁcantly higher in male children compared to that of adult males. Overall females have signiﬁcantly MEP higher concentration than males. b: The body-weight-unadjusted
MEP concentration in male children is signiﬁcantly lower compared to that in adults. Overall there was no signiﬁcant difference in the MEP concentration amongmales and females.
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weight (μg/kg-bw/day) and unadjusted for body weight (μg/day)
were computed. In Tables 1 and 2, the median LSGM estimates, and
median 95% CIs for MEP excretion rates and DEP daily intakes are pre-
sented. Both unadjusted and body-weight-adjusted estimates show a
similar trend in the excretion rates. In general, the LSGM estimates
increase with age and the excretion rate in children is signiﬁcantly
lower compared to adolescents and adults. Female children had signiﬁ-
cantly lower excretion rates compared to females in the adolescents and
adults category when bodyweight was not taken into account. However
these differenceswere not signiﬁcant when the bodyweight adjustment
was included. Likewise, in body-weight-unadjusted models, males in0.84 0.75
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Fig. 2. Trends in the least square geometric mean (LSGM) estimates of monoethyl phthalate (M
conﬁdence intervals on the LSGM. Statistically signiﬁcant (p b 0.05) differences are noted with
children compared to adolescents and adults. Overall therewas no signiﬁcant difference in the e
rates in children were signiﬁcantly lower compared to adolescent and adults. In addition, the m
there was no signiﬁcant difference in the excretion rates between males and females.different age groups had signiﬁcantly different excretion rates compared
to one another with children having the lowest excretion rates. When
adjusted for body weight, only the comparison between male children
and males in adolescent and adults was signiﬁcant.
4. Discussion and conclusion
Major source of exposure to DEP in the general population stems
from the use of cosmetic and PCPs that contain DEP (ATSDR. 1995).
However, DEP is not explicitly speciﬁed as an ingredient in several con-
sumer products and often captured under the general term “parfum”.
PCPs such as deodorants, fragrance, and aftershaves that are usually26.39 24.08
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EP) excretion rates in the general Canadian population.Whiskers represent the upper 95%
an asterisk (*). a: MEP excretion rate adjusted for body weight was signiﬁcantly lower in
xcretion rates betweenmales and females. b: The body-weight-unadjustedMEP excretion
ale adolescents have signiﬁcantly lower excretion rates compared to male adults. Overall
Table 1
Urinary monoethyl phthalate (MEP) daily excretion rates, adjusted and unadjusted for body weight, in the general Canadian population using the urine volume approach.
Age group
(years)
Sex n % bLOD MEP excretion rate (μg/kg-bw/day) (adjusted for BW) MEP excretion rate (μg/day) (unadjusted for BW)
Median 95% LCL Median LSGM Median 95% UCL Median 95% LCL Median LSGM Median 95% UCL
6-1.1 Females 511 0.00 0.46 0.57 0.71 14.45 18.05 22.57
Males 521 0.19 0.33 0.47 0.67 11.07 15.24 20.93
12–19 Females 484 0.00 0.72 0.90 1.13 41.27 52.45 66.71
Males 504 0.00 0.66 0.82 1.02 42.45 51.86 63.75
20–49 Females 608 0.00 0.58 0.77 1.01 39.00 52.07 69.15
Males 596 0.00 0.84 1.06 1.35 68.31 87.17 112.26
Urine ﬂow rate (matched for age, sex and body mass index) for individual participants was imputed from NHANES 2009–2010 dataset and used to estimate the total urine output. The
imputation was carried out 500 times. For each bootstrap sample of urinary ﬂow rates drawn fromNHANES, the least square geometric mean (LSGM) of the excretion rate was estimated
using themultiple regressionmodel (see text for details). The table shows themedian LSGM and associated 95% conﬁdence interval of the excretion rates for different age and sex groups.
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sources of DEP exposure (Wormuth et al., 2006). Moreover, PCPs such
asmouthwash, toothpaste and lip products that could be orally ingested
are not major exposure sources (NICNAS, 2011). In addition, DEP is not
widely detected in toys and children's articles that contain plastic parts.
Exposure to DEP could also occur due to ingestion of contaminated food
and seafood or drinking contaminated water (ATSDR, 1995).
We used multiple regression modeling to assess associations
between body weight and urinary MEP concentration as well as DEP
daily intake derived from the urinary MEP concentration data in
CHMS 2007–2009. The ﬁnal regression model included age, sex and
urinary creatinine concentration. In our previous work we found that
fasting status did not signiﬁcantly affect the MEP concentration
(p N 0.05) (Saravanabhavan et al., 2013). Therefore, fasting status was
excluded from the multiple regression modeling. Age and sex group
comparisons of the LSGM concentrations of MEP presented in Fig. 1a
and b show that body-weight-adjusted MEP concentrations in male
children were signiﬁcantly higher compared to adolescents and adults
even though the unadjusted concentrations showed the opposite
trend. Due to relatively lower body weight of children, equal or even
lower measured urinary concentration compared to adults might sug-
gest higher instantaneous body burden.
We have used the creatinine correction approach and urine volume
approaches for calculatingDEP daily intakes in Canadians using a simple
one compartment pharmacokinetic model (David, 2000; Frederiksen
et al., 2011; Koch et al., 2006a; Kohn et al., 2000). Earlier studies that
estimated daily intakes of the environmental chemicals from the bio-
monitoring data used average data for the physiological parameters
such as creatinine excretion rates, daily urine output and body weight
(David, 2000; Koch et al., 2003; Kohn et al., 2000; Lakind and Naiman.
2008). However, it is very difﬁcult to estimate the variability in those
daily intake estimates as the physiological parameters used are known
to vary considerably among different age groups as well as between
the individuals within a given age group. Therefore, to derive a robust
estimate of DEP daily intake, we have estimated the physiological pa-
rameters for each individual and used them to compute the individual's
daily intake. We have used the creatinine excretion rate equationsTable 2
Diethyl phthalate (DEP) daily intake rates, adjusted and unadjusted for body weight, in the ge
Age group
(years)
Sex n % bLOD DEP daily intake (μg/kg-bw/day
Median 95%LCL
of LSGM
Median
LSGM
6–11 Females 511 0.00 0.76 0.95
Males 521 0.19 0.55 0.78
12–19 Females 484 0.00 1.19 1.50
Males 504 0.00 1.10 1.36
20–49 Females 608 0.00 0.96 1.27
Males 596 0.00 1.39 1.76
Urine ﬂow rate (matched for age, sex and body mass index) for individual participants was im
imputation was carried out 500 times. For each bootstrap sample of urinary ﬂow rates drawn f
using themultiple regressionmodel (see text for details). The table shows themedian LSGM anderived by Mage et al. (as depicted in Huber et al., 2010) to estimate
the creatinine excretion rate. These equations take into account age,
sex, height, weight, and BMI of the individual participants to estimate
the creatinine excretion rates. As the urine ﬂow rate is known to vary
due to several factors including age, sex and BMI, we have matched
the NHANES participant's data for age, sex and BMI with that of CHMS
participants during the imputation process. We have estimated the
daily urine output (mL/day) from the urine ﬂow rate (mL/min) by
assuming a constant urine ﬂow rate in the survey participants. Thus
the imputation process introduced additional bootstrap variability to
the overall variability estimates of the model outputs.
In Fig. 3 the DEP daily intakes in the sub-population using the
creatinine correction and urine volume approaches are presented.
We observed that children had signiﬁcantly lower DEP daily intake
(μg/kg-bw/day) compared to adults and adolescents. Our results are
consistent with the intake estimates computed using deterministic
and probabilistic exposure models (NICNAS, 2011; Wormuth et al.,
2006). Moreover, these exposure models suggest that DEP exposure in
all age groups is from similar sources, among which the use of personal
care product dominates. In addition, DEP levels in PCPs that are normally
used by infants, toddlers and children are lower than the PCPs used by
adolescents and adults thus suggesting a lower exposure in children
(Cosmetic Ingredient Review Expert Panel, 2005).
Both creatinine approach as well as the urine volume approach
produced similar trends in the daily intakes with respect to age
and sex. For example, the LSGM DEP daily intake estimates using the
creatinine approach for children, adolescent and adults were 1.31
(95% CI: 1.08–1.58), 1.92 (95%CI: 1.70–2.17) and 2.10 (95% CI: 1.80–
2.44) μg/kg-bw/day respectively while the median LSGM estimates
of daily intakes for the above age groups computed using urine volume
approach were 0.864, 1.428 and 1.496 μg/kg-bw/day respectively.
Moreover, we did not observe any signiﬁcant differences in the daily
intake estimates among males and females within any given age group
as well as in the overall population.
Although the creatinine correction approach consistently produced
higher daily intake estimates than the urine ﬂow approach, the esti-
mates were similar to each other when both the sampling variabilityneral Canadian population using the urine volume approach.
) (adjusted for BW) DEP daily intake (μg/day) (unadjusted for BW)
Median 95% UCL
OF LSGM
Median 95% LCL
of LSGM
Median
LSGM
Median 95% UCL
of LSGM
1.18 23.96 29.94 37.44
1.11 18.36 25.28 34.72
1.88 68.45 86.99 110.65
1.68 70.42 86.01 105.73
1.68 64.69 86.37 114.70
2.23 113.30 144.59 184.55
puted from NHANES 2009–2010 dataset and used to estimate the total urine output. The
rom NHANES, the least square geometric mean (LSGM) of the daily intake was estimated
d associated 95% conﬁdence interval of the excretion rates for different age and sex groups.
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Fig. 3. Trends in the least square geometric mean (LSGM) estimates of diethyl phthalate (DEP) daily intakes in the general Canadian population calculated using creatinine correction
(dots) and urine ﬂow rate (stripes) approaches. The daily intake estimates produced by both approaches were similar. The error bars for LSGM estimate for creatinine approach reﬂect
the 95% conﬁdence interval computed using the multiple regression modeling. The error bars on the LSGM estimates of urine volume approach indicate the upper 95% conﬁdence levels
of themedian LSGM. DEP daily intakes calculated using creatinine approachwere signiﬁcantly lower (as noted in Fig. 2a) in bothmale and female children compared to respective sexes in
adolescent and adult categories. However the DEP daily intake calculated using urine volume approachwas signiﬁcantly lower only inmale children compared tomales in adolescent and
adult categories. Overall females andmales did not have signiﬁcant difference in the daily intake rates. To improve clarity, the signiﬁcant differences between sub-population are noted in
the ﬁgure only on the intake estimates computed using the urine volume approach.
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account (Fig. 3). In addition, the urine volume approach produced
LSGM estimates for each bootstrapping iteration (500 in total) and
therefore in Fig. 3 themedian LSGM (and the associated 95% conﬁdence
level of the median) was compared with the LSGM estimate (and asso-
ciated 95% conﬁdence interval) from the creatinine approach. Therefore,
we recommend caution in the generalization of these results.
We observed a higher body-weight-adjusted urinary MEP concen-
tration (μg/L/kg-bw) in children compared to adolescents and adults.
Clearly, a lower absolute daily urine output in children compared to
adults (L/d) resulted in lower estimated daily intake (see Eqs. (1a),
(1b) and (2)). Theoretically, collection of 24-h composite urine samples
from study participants is the best approach to adjust for urine dilution
effects; however, due to practical limitations this approach is hardly
followed in large-scale biomonitoring surveys. Estimation of total
urine output based on the urine ﬂow rates appears promising and hasTable 3
Diethyl phthalate (DEP) daily intake estimates in the general Canadian population based on ur
n A.M. (95% CI) G.M. (95% CI) 10th (95% CI) 25th
Total 3224 5.9 (4.3–7.4) 2.1 (1.8–2.3) 0.48 (0.42–0.53) 0.8 (0
6–11 years 1032 2.6 (1.8–3.4) 1.3 (1.1–1.6) 0.48 (0.4–0.57) 0.74
12–19 years 988 4.2 (3.4–5.1) 1.9 (1.7–2.1) 0.54 (0.45–0.62) 0.87
20–49 years 1204 6.7 (4.8–8.7) 2.2 (1.9–2.6) 0.47 (0.42–0.53) 0.8 (0
Males
Total 1621 6.2 (4.1–8.3) 2 (1.7–2.3) 0.46 (0.38–0.54) 0.76
6–11 years 521 2.5 (1.7–3.2) 1.2 (0.96–1.5) 0.46 (0.38–0.53) 0.69
12–19 years 504 4.1(2.9–5.3) 1.8 (1.5–2) 0.48 (0.39–0.58) 0.78
20–49 years 596 7.2E (4.5–10) 2.3 (1.9–2.7) 0.45 (0.34–0.55) 0.79
Females
Total 1603 5.5 (3.5–7.5) 2.1 (1.7–2.4) 0.49 (0.43–0.56) 0.84
6–11 years 511 2.7E (1.4–4) 1.4 (1.1–1.7) 0.52 (0.43–0.6) 0.76
12–19 years 484 4.3 (3.3–5.4) 2.1 (1.8–2.4) 0.54 (0.46–0.63) 1 (0.8
20–49 years 608 6.2E (3.5–8.9) 2.2 (1.8–2.7) 0.48 (0.41–0.54) 0.82
E, use data with caution.
F, data is too unreliable to be published.been used in NHANES since 2010. In addition, creatinine adjustment
approach has been widely used to account for urine dilution effects
although its use in exposure assessment for certain sub-populations
(e.g. infants) is questionable. In thiswork,we found that the daily intake
produced using creatinine correction approach and that using the urine
volume approach are similar to each other. Due to its simplicity, we
prefer the usage of creatinine correction approach when urine ﬂow
rate information is not available.
In Table 3 the descriptive statistics on the DEP daily intake estimates
for the Canadian population is presented. The estimated geometricmean
and the 95th percentile of DEP daily intake in the general Canadian
population (6–49 years) are 2 and 20 μg/kg-bw/day. These are relatively
lower than the DEP daily intake estimates of 5.5 μg/kg-bw/day (geo-
metric mean) and 61.7 μg/kg-bw/day (95th percentile) reported in
the US general population (6 to N20 years) using NHANES 1999–2000
dataset (Calafat and McKee, 2006). In 214 mother–infant pairs ininary monoethyl phthalate (MEP) data from the CHMS 2007–2009.
(95% CI) 50th (95% CI) 75th (95% CI) 90th (95% CI) 95th (95% CI)
.72–0.88) 1.7 (1.4–1.9) 3.9 (3.2–4.6) 10E (5.9–14) 21E (9.4–32)
(0.63–0.84) 1.1 (0.91–1.2) 2.1 (1.6–2.5) 4.2E (1.9–6.5) 7.3E (3.2–11)
(0.72–1) 1.6 (1.4–1.9) 3.7 (3–4.3) 8.4 (6.8–9.9) 15 (12–18)
.71–0.9) 1.9 (1.6–2.2) 4.4 (3.1–5.6) 12E(5.9–18) 23E (7.9–39)
(0.64–0.88) 1.7 (1.3–2) 4.1 (3.2–5) 12E (6.3–17) F
(0.58–0.8) 1 (0.82–1.2) 2E (1.1–2.8) 4.6E (1.6–7.6) 7E (4.3–9.6)
(0.64–0.93) 1.5 (1.3–1.8) 3.6 (2.7–4.4) 7.7E (2.4–13) 17 (11–23)
(0.62–0.96) 1.9 (1.5–2.3) 4.9 (3.5–6.3) 14E (5.8–22) F
(0.75–0.92) 1.7 (1.4–1.9) 3.8 (2.9–4.6) 9E (4.4–14) 18E (8.5–27)
(0.66–0.87) 1.1 (0.87–1.4) 2.2 (1.8–2.5) 4E (1.4–6.6) F
8–1.2) 1.8 (1.5–2.2) 4.2 (2.7–5.6) 8.4 (6.7–10) 14 (10–17)
(0.71–0.92) 1.7 (1.3–2.1) 4 (2.7–5.4) F 21E (7.6–35)
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metabolite concentrations, Marsee et al. estimated a DEP daily intake
of 6.64 μg/kg-bw/day (median) and 112.3 μg/kg-bw/day (95th per-
centile) (Marsee et al., 2006). Based on the MEP concentration in
the ﬁrst morning urine samples, Koch et al. (Koch et al., 2003) esti-
mated the DEP daily intake estimates of 2.32 μg/kg-bw/day (median)
and 22.1 μg/kg-bw/day (95th percentile) in the general population in
Germany (n = 85; age 7–63 years). Using the urinary MEP and the
24-h urine volume data, Ferderkisen et al. calculated a DEP daily intake
in 129 Danish children (Frederiksen et al., 2011). The reported median
daily intake estimates of 0.92 (6–10 years) and 0.98 (11–16 years) are
similar to the median estimates for the respective age groups derived
in this work (Table 3).
We observed a good correlation between urinaryMEP concentration
and daily intake in the overall population (data not shown). However,
one should be cautious when directly using the urinary concentrations
to compare the intake trends in the sub-populations (e.g. children vs.
adults). For example, although the CHMS 2007–2009 data show that
children have more than two fold lower geometric mean urinary MEP
concentration (25.85 μg/L) compared to adults (60.56 μg/L) (Health
Canada, 2010), the geometric mean of DEP daily intakes calculated for
children (1.3 μg/kg-bw/day) and adults (2.2 μg/kg-bw/day) differ by
less than two fold (Table 3). Thus, trends in intake estimates are governed
not only by the urinary concentration but also by other physiological
factors (such as total urine output and body weight).
Several reports and publications exist on the toxicity of diethyl
phthalate (Api, 2001; ATSDR, 1995). In general, exposure to high
doses of DEP (≥750 mg/kg-bw/day) appears to induce decreased
growth rate and food consumption and alter organ weights in animal
studies (US EPA, 2012). Reproductive and developmental toxic effects
that are characteristics of some phthalate diesters do not appear to be
critical in the case of DEP (ATSDR, 1995). The US EPA has derived an
oral reference dose (RfD) of 800 μg/kg-bw/day for DEP based on the
no observed effects level (NOEL) of 750 mg/kg-bw/day. The Concise
International Chemical Assessment Document (CICAD) of International
Programme on Chemical Safety (IPCS) suggests a DEP tolerable daily
intake value of 5000 μg/kg-bw/day. The DEP daily intake estimates at
the geometric mean and the 95th percentile in the Canadian population
are about 400 times and 40 times lower than the US EPA's RfD suggest-
ing a relatively low risk due to current exposure levels.
Limitations and uncertainties
• The estimation of daily intake rates in this analysis implicitly as-
sumes that measured spot sample concentrations are representa-
tive of 24-h average concentrations. Kao et al. (Kao et al., 2012)
suggested an elimination half-life of about 1 h in dogs, which is
similar to the elimination half-life of other phthalate monoesters
(Koch et al., 2006b). Therefore, the urinary MEP concentration in an
individual is expected to vary considerably in spot-urine samples
collected within the same day (Frederiksen et al., 2012; Preau et al.,
2010; Silva et al., 2004).
• Hence, extremes of the daily intake estimates may not be representa-
tive of longer-term average exposure in individuals, but may instead
reﬂect peaks and troughs in the daily urinary concentration vs. time
proﬁles expected following exposures to transient compounds
(Aylward et al., 2012). Therefore, the intake estimates at the extremes
of the distributions should be interpreted with some caution.
• The imputation of urinary ﬂow rate data from NHANES 2009–2010
for the estimation of daily intake for CHMS participants using urine
volume approach introduced an additional source of uncertainty.
• Moreover, in this work we have used a simplistic one compartment
model for estimating daily intakes of DEP which does not take into
account any partitioning characteristics of DEP in humans. More
complex multi-compartment reverse dosimetry models had been
developed to produce exposure estimates from biomonitoring data
for some chemicals (e.g. blood VOCs).• In addition, we have assumed that everybody in the sub-population
have identical urinary excretion factor (FUE) of 0.69 for MEP. There-
fore, this study did not take into account any systemic variability in
the FUE.
In conclusion, the bodyweight appears to inﬂuence the urinaryMEP
concentration trend signiﬁcantly when used to compare the exposure
patterns between population sub-groups. The creatinine correction
approach is found to be relatively simple for the calculation of DEP
daily intake estimates. Although we observed a good correlation be-
tween urinary concentrations and daily intake estimates in the overall
population, we recommend caution when directly using the urinary
concentrations to compare the intake trends in the sub-populations
(e.g. children vs. adults). Our analysis shows that the DEP daily intakes
in children are signiﬁcantly lower compared to adults while there is
no difference between the daily intake estimates between adolescents
and adults. Finally, the estimated DEP daily intake in the Canadian pop-
ulation is about two orders of magnitude lower than the US EPA RfD
suggesting that current exposure levels are low relative to exposure
levels of concern based on the current risk assessments.
References
Albro PW, Moore B. Identiﬁcation of the metabolites of simple phthalate diesters in rat
urine. J Chromatogr A 1974;94:209–18.
Api AM. Toxicological proﬁle of diethyl phthalate: a vehicle for fragrance and cosmetic
ingredients. Food Chem Toxicol 2001;39:97–108.
ATSDR. Toxicological proﬁle for diethyl phthalate (DEP); 1995.
Aylward LL, Kirman CR, Adgate JL, McKenzie LM, Hays SM. Interpreting variability in pop-
ulation biomonitoring data: role of elimination kinetics. J Expo Sci Environ Epidemiol
2012;22:398–408.
Becker K, Gnen T, Seiwert M, Conrad A, Pick-Fuß H,Mnller J, et al. GerES IV: phthalateme-
tabolites and bisphenol A in urine of German children. Int J Hyg Environ Health 2009;
212:685–92.
Blount BC, Silva MJ, Caudill SP, Needham LL, Pirkle JL, Sampson EJ, et al. Levels of seven
urinary phthalate metabolites in a human reference population. Environ Health
Perspect 2000;108:979–82.
Calafat AM, McKee RH. Integrating biomonitoring exposure data into the risk assessment
process: phthalates [diethyl phthalate and di (2-ethylhexyl) phthalate] as a case
study. Environ Health Perspect 2006;114:1783.
CDC. Fourth national report on human exposure to environmental chemicals, updated
tables. 2012last accessed November 22 http://www.cdc.gov/exposurereport/pdf/
FourthReport_UpdatedTables_Sep2012.pdf, 2012.
Cosmetic Ingredient Review Expert Panel. Annual review of cosmetic ingredient safety
assessment—2002/2003. Int J Toxicol 2005;24(Suppl.1):1–102.
David RM. Exposure to phthalate esters. Environ Health Perspect 2000;108:A440.
Efron B, Tibshirani R. Bootstrap methods for standard errors, conﬁdence intervals, and
other measures of statistical accuracy. Stat Sci 1986;1:54–75.
Frederiksen H, Aksglaede L, Sorensen K, Skakkebaek NE, Juul A, Andersson AM. Urinary
excretion of phthalate metabolites in 129 healthy Danish children and adolescents:
estimation of daily phthalate intake. Environ Res 2011;111:656–63.
Frederiksen H, Kranich SK, Jørgensen N, Taboureau O, Petersen JH, Andersson A. Temporal
variability in urinary phthalate metabolite excretion based on spot, morning, and
24-h urine samples: considerations for epidemiological studies. Environ Sci Technol
2012;47:958–67.
Fromme H, Lahrz T, Piloty M, Gebhart H, Oddoy A, Rüden H. Occurrence of phthalates and
musk fragrances in indoor air and dust from apartments and kindergartens in Berlin
(Germany). Indoor Air 2004;14:188–95.
Health Canada. Report on human biomonitoring of environmental chemicals in Canada;
2010.
Houlihan J, Brody C, Schwan B. Not too pretty. Phthalates, beauty products & the FDA;
2000.
Huber DR, Blount BC, Mage DT, Letkiewicz FJ, Kumar A, Allen RH. Estimating perchlorate
exposure from food and tap water based on US biomonitoring and occurrence data.
J Expo Sci Environ Epidemiol 2010;21:395–407.
Hubinger JC, Havery DC. Analysis of consumer cosmetic products for phthalate esters.
J Cosmet Sci 2006;57:127–37.
Kao ML, Ruoff B, Bower N, Aoki T, Smart C, Mannens G. Pharmacokinetics, metabolism
and excretion of 14C-monoethyl phthalate (MEP) and 14C-diethyl phthalate (DEP)
after single oral and IV administration in the juvenile dog. Xenobiotica 2012;42:
389–97.
Koch HM, Calafat AM. Human body burdens of chemicals used in plastic manufacture.
Philos Trans R Soc B Biol Sci 2009;364:2063–78.
Koch HM, Drexler H, Angerer J. An estimation of the daily intake of di(2-ethylhexyl)
phthalate (DEHP) and other phthalates in the general population. Int J Hyg Environ
Health 2003;206:77–83.
Koch HM, Becker K, Wittassek M, Seiwert M, Angerer J, Kolossa-Gehring M. Di-n-
butylphthalate and butylbenzylphthalate—urinary metabolite levels and estimated
daily intakes: pilot study for the German Environmental Survey on children. J Expo
Sci Environ Epidemiol 2006a;17:378–87.
198 G. Saravanabhavan et al. / Science of the Total Environment 500–501 (2014) 191–198Koch HM, Preuss R, Angerer JD. Di (2‐ethylhexyl) phthalate (DEHP): human metabolism
and internal exposure—an update and latest results1. Int J Androl 2006b;29:155–65.
Kohn MC, Parham F, Masten SA, Portier CJ, Shelby MD, Brock JW, et al. Human exposure
estimates for phthalates. Environ Health Perspect 2000;108:A440.
Koniecki D, Wang R, Moody RP, Zhu J. Phthalates in cosmetic and personal care products:
concentrations and possible dermal exposure. Environ Res 2011;111:329–36.
Lakind JS, Naiman DQ. Bisphenol A (BPA) daily intakes in the United States: estimates
from the 2003–2004 NHANES urinary BPA data. J Expo Sci Environ Epidemiol 2008;
18:608–15.
Langlois É, LeBlanc A, Simard Y, Thellen C. Accuracy investigation of phthalate metabolite
standards. J Anal Toxicol 2012;36:270–9.
Marsee K, Woodruff TJ, Axelrad DA, Calafat AM, Swan SH. Estimated daily phthalate
exposures in a population of mothers of male infants exhibiting reduced anogenital
distance. Environ Health Perspect 2006;114:805.
NICNAS. Priority Existing Chemical (PEC) assessment report # 33—diethyl phthalate
(DEP). National Industrial Chemicals Notiﬁcation and Assessment Scheme, Sydney,
NSW; 2011 [Available online at http://www.nicnas.gov.au/chemical-information/
pec-assessments].
Preau Jr JL,Wong L, SilvaMJ, Needham LL, Calafat AM. Variability over 1week in the urinary
concentrations of metabolites of diethyl phthalate and di(2-ethylhexyl) phthalate
among eight adults: an observational study; 2010. p. 118.R Core Team. R: a language and environment for statistical computing. Available online at
http://www.R-project.org/R Foundation for Statistical Computing ; 2013.
Romero-Franco M, Hernández-Ramírez RU, Calafat AM, Cebrián ME, Needham LL,
Teitelbaum S, et al. Personal care product use and urinary levels of phthalate metab-
olites in Mexican women. Environ Int 2011;37:867–71.
Saravanabhavan G, Guay M, Langlois É, Giroux S, Murray J, Haines D. Biomonitoring of
phthalate metabolites in the Canadian population through the Canadian Health Mea-
sures Survey (2007–2009). Int J Hyg Environ Health 2013;216:652–61.
Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, et al. Urinary levels of seven
phthalate metabolites in the U.S. population from the National Health and Nutrition
Examination Survey (NHANES) 1999–2000. Environ Health Perspect 2004;112:331–8.
Thornton JW, McCally M, Houlihan J. Biomonitoring of industrial pollutants: health and
policy implications of the chemical body burden. Public Health Rep 2002;117:315.
US EPA. IRIS summary for diethyl phthalate. US EPA; 2012 [2014January. Available online
at http://www.epa.gov/iris/subst/0226.htm].
WHO. Concise international chemical assessment document—diethyl phthalate. World
Health Organisation; 2003. p. 52.
Wormuth M, Scheringer M, Vollenweider M, Hungerbühler K. What are the sources of
exposure to eight frequently used phthalic acid esters in Europeans? Risk Anal
2006;26:803–24.
